INHIBACE
CHEPLAPHARM ARZNEIMITTEL GMBH
Quick answers
Is there a shortage of INHIBACE in Canada?
No. There is no current shortage of INHIBACE 5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
APO-CILAZAPRIL
APOTEX INC
NTP-CILAZAPRIL
TEVA CANADA LIMITED
Other Products
CO CILAZAPRIL
COBALT PHARMACEUTICALS COMPANY
TEVA-CILAZAPRIL
TEVA CANADA LIMITED
DOM-CILAZAPRIL
DOMINION PHARMACAL
PHL-CILAZAPRIL
PHARMEL INC
DIN
01911481
Strength
5MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
CILAZAPRIL (CILAZAPRIL MONOHYDRATE)
See all CILAZAPRIL (CILAZAPRIL MONOHYDRATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from CHEPLAPHARM ARZNEIMITTEL GMBH
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MG · DIN 02221861
4MG · DIN 02239090
16MG · DIN 02239092
32MG · DIN 02311658
8MG · DIN 02239091
DIN 02332922
DIN 02244021
DIN 02332957
500MG · DIN 02162695
50MG · DIN 00029149
500MG · DIN 00465283
2.5MG · DIN 01911473